Phase 2 Study to Assess the Safety and Efficacy of ANG003
Phase 2 Study to Assess the Safety and Efficacy of ANG003
Recruiting · NCT07450547 · Registry updated 2026-10-06Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Phase 2 Study to Assess the Safety and Efficacy of ANG003 | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Digestive System Diseases, Infant, Newborn, Diseases, cystic fibrosis, exocrine pancreatic insufficiency, hereditary disease, lung disorder, pancreas disorder, respiratory system disorder | Recruiting | Phase 2 | 2026-10-06 | NCT07450547 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Anagram Therapeutics, Inc. | 1 |
27 results · Page 1 of 2
Research sites
Swipe the table sideways for more columns.